跳至主要内容
临床试验/ISRCTN95653203
ISRCTN95653203已完成不适用

se of non steroidal aromatase inhibitors in treatment of patients with early invasive hormone-dependent breast cancer in everyday clinical practice: non-interventional, multicentre study

PLIVA Croatia Ltd. (Croatia)0 个研究点目标入组 500 人开始时间: 2011年6月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • 1. Patients with early invasive breast cancer
  • 2. Hormone-dependent disease
  • 3. Postmenopausal women
  • 4. Eastern Cooperative Oncology Group (ECOG) 0-1
  • 5. Signed informed consent

排除标准

  • 1. Metastatic breast cancer
  • 2. Premenopausal women
  • 3. Pregnancy or lactation
  • 4. Patients with severe renal impairment
  • 5. Patients with moderate to severe hepatic disease
  • 6. Known hypersensitivity to anastrozole or letrozole or any of the excipients
  • 7. Concurrent oestrogen containing therapy
  • 8. Concurrent tamoxifen therapy
  • 9. Previous treatment with tamoxifen
  • 10. Previous treatment with any other aromatase inhibitor

研究者

相似试验

招募中
2 期
Investigation of the effect of letrozole in the treatment of ectopic pregnancies compared to methotrexate.
IRCT20170828035961N2Esfahan University of Medical Sciences40
进行中(未招募)
1 期
PARAGON - Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological neoplasmsPatients with potentially hormone responsive recurrent or metastatic gynaecological cancers from following subgroups:A - Epithelial ovarian cancer, primary peritoneal cancers and cancers of the fallopian tubeB- Endometrial cancerC- Endometrial Stromal SarcomasD- Miscellaneous SarcomasE- Granulosa Cell Tumours and other Sex Tumours * UK sites will only enter patients to subgroups B-E *MedDRA version: 14.1Level: LLTClassification code 10026310Term: Malignant neoplasm of ovarySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10014760Term: Endometrial neoplasm malignantSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2011-000501-52-GBGreater Glasgow and Clyde350
招募中
3 期
MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancerepithelial ovarian cancer
2024-511219-78-00Swiss GO Trial Group300
进行中(未招募)
1 期
MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancerPatients with low and high grade serous and endometrioid ovarian cancer patients.
EUCTR2019-002264-27-ATSwiss GO Trial Group540
招募中
3 期
Effect of Aromatase inhibitors combination with oral contraceptive pills versus GnRH agonist on uterine myomaterine Myoma.Leiomyoma of uterus
IRCT20140820018866N7Tehran University of Medical Sciences42